Current News Releases
Current News Releases
A novel two-drug combination has the potential to target and restore a defective protein underlying cystic fibrosis (CF), according to two phase III clinical trials conducted at 187 medical centers around the world, including Johns Hopkins.
Julie Lange, M.D., an associate professor of surgery, oncology and dermatology at the Johns Hopkins University School of Medicine, and John Fetting, M.D., an associate professor of oncology and medicine, have been inducted into the Miller-Coulson Academy of Clinical Excellence.
A distinguished group of 268 graduates will embark on their future careers as physicians and scientists at the convocation ceremony of the Johns Hopkins University School of Medicine. A total of 113 M.D. degrees, 138 Ph.D. degrees, 15 master’s degrees and two postbaccalaureate certificates will be conferred.
A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide.
Sending teen girls periodic text messages reminding them to follow through on their clinic appointments for periodic birth control injections can go a long way toward improving timing and adherence to contraception in an age group that is notoriously noncompliant, according to a small study from the Johns Hopkins Children’s Center.
Study of thousands of human bones reveals gradual decline as species grew more “domestic”
Modern lifestyles have famously made humans heavier, but, in one particular way, noticeably lighter weight than our hunter-gatherer ancestors: in the bones. Now a new study of the bones of hundreds of humans who lived during the past 33,000 years in Europe finds the rise of agriculture and a corresponding fall in mobility drove the change, rather than urbanization, nutrition or other factors.
Site aims to help consumers decipher the institution’s performance scores and make better-informed health care decisions
New building will accommodate more local startups
A groundbreaking ceremony will be held for 1812 Ashland on Friday, May 15. The building will house Johns Hopkins offices, including FastForward East, a program designed to move academic findings and translational research into the commercial marketplace.
Sahar Soleimanifard, a first-year medical student at The Johns Hopkins University, is among 30 graduate students receiving 2015 Paul and Daisy Soros Fellowships for New Americans.
Johns Hopkins Medicine announced today the appointment of Robert A. Kasdin to the newly created role of senior vice president and chief operating officer. Kasdin comes to Johns Hopkins Medicine from Columbia University, where he has been senior executive vice president since 2002. He starts on July 1.
Increasingly common illness has high toll: 300,000 stricken, $1.3 billion in treatment costs per year
Fundamental research into the causes and cures of post-treatment Lyme disease syndrome now has its first home base at a major U.S. medical research center with the launch of the Johns Hopkins Lyme Disease Clinical Research Center.
The culmination of the DreamIt Health Baltimore accelerator program, a four-month intensive boot camp for health information technology entrepreneurs co-sponsored by Johns Hopkins, concludes on Wednesday, May 13, at DreamIt Health Demo Day. This one-day capstone event affords startup companies the opportunity to share their progress and plans for the future with an audience of industry leaders, possible investors and potential customers.
Observational study does not prove cause and effect, researchers caution
Nonsmokers sharing an unvented area with heavy marijuana smokers in some cases may not have passed a drug screen
Secondhand exposure to cannabis smoke under “extreme conditions,” such as an unventilated room or enclosed vehicle, can cause nonsmokers to feel the effects of the drug, have minor problems with memory and coordination, and in some cases test positive for the drug in a urinalysis. Those are the findings of a Johns Hopkins University School of Medicine study, reported online this month in the journal Drug and Alcohol Dependence.
Pilot program designed as a model for corporations and nonprofits nationwide
Johns Hopkins Medicine has created and launched Managing Cancer at Work, a new and novel health benefit program offered free of charge for its more than 42,000 combined full-time equivalent employees. Developed by a team of Johns Hopkins Medicine staff members, several of whom are also cancer survivors, the program is designed to aid employees who are at risk for cancer, have cancer, or are caring for someone with the disease. It offers information and guidance as well to supervisors about supporting workers who are managing employees with the disease.
Hear brief presentations about innovative ideas that offer solutions to several health care challenges.
Heart disease has topped mortality charts as the No. 1 killer of men and women for many decades, but a novel analysis of American literary fiction by two physicians finds the disorder’s presence in great novels has remained relatively modest.
New study reveals how important neurons find their way from the retina to the inner brain
Just as most cameras now have an autostabilization feature to compensate for movement during picture taking, our eyes execute an imperceptible reflex that prevents our vision from blurring when we, or our field of vision, are in motion. But before the reflex can work, the wirelike projections, or axons, of specialized nerve cells must find their way from the retina to the correct part of the brain during embryonic development. New research describes how those axons find their way through the brain’s maze of neurons to make the right connection. The finding has implications for treatment of eye movement disorders and regeneration of damaged vision-sensing nerve cells.